Ginger.io

By Jonah Comstock 09:28 am November 28, 2012
Behavior monitoring and analytics startup Ginger.io has raised $6.5 million dollars in its first round of funding, led by increasingly frequent digital health investor Khosla Ventures. Existing investors from the company's $1.7 million seed round in October 2011, True Ventures and Romulus Capital, also contributed. Ginger.io, which absorbed mobile health startup Pipette earlier this year, offers...
By Brian Dolan 04:44 am September 4, 2012
At the end of August the White House launched a new program, the Presidential Innovation Fellows program, which pairs the private sector, academia, and non-profits with people from the government to work on five innovation projects over the course of the next five months. One of those projects is one that is undoubtedly familiar to those working in healthcare today: The Open Data Initiative....
By Brian Dolan 11:08 am April 2, 2012
San Francisco-based digital health incubator Rock Health announced plans to expand with a new program in Boston set to kickoff this June, according to the Boston Globe's tech columnist Scott Kirsner. Unlike the five-month long spring and fall programs that Rock Health offers in San Francisco, the Boston program's duration will be three months: June to August. While the programs have different...
By Brian Dolan 11:06 am March 9, 2012
Ginger.io, a behavioral analytics company that spun out of the MIT Media Lab, announced this week that mobile health startup, Pipette, will be folded into Ginger.io. The company adds both Pipette's software and its two founders. Notably, Pipette was a part of the San Francisco-based Rock Health incubator program, where it developed mobile health offerings that enable hospitals and care teams to...
By Chris Gullo 08:21 am October 18, 2011
Social behavior analysis startup Ginger.io recently announced $1.7 million in its first round of funding. The start-up, which was born out of MIT's Media Lab, is developing software for mobile devices that aims to give pharma companies and providers detailed data on patient behavior to more effectively target new drugs and therapies. The round was led by Silicon Valley-based True Ventures and...